RecallDepth
Class I Terminated

MitoXANTRONE Injection, USP, (concentrate) 2 mg/mL, Rx Only. Hospira, Lake Forest, IL 60045, Product of Australia. Available in a) 20 mg/10 mL Multi Dose Vial (NDC: 61703-343-18); b) 25 mg/12.5 mL Multi Dose Vial (NDC: 61703-343-65); c) 30 mg/15 mL Multi Dose Vial (NDC: 61703-343-66).

Company
Hospira Inc.
Recall Initiated
December 3, 2014
Posted
April 15, 2015
Recall Number
D-0433-2015
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
13,792 Vials (U.S.)
Firm Location
Lake Forest, IL, United States

Reason for Recall

Failed Stability Specifications: Product is subpotent and has out of specification known and unknown impurities.

Distribution

US: Nationwide including Puerto Rico; Australia, Canada, Cyprus, Egypt, Ireland, Saudi Arabia, Qatar, Oman, Bahrain, and United Kingdom.

Lot / Code Info

LOTS DISTRIBUTED IN THE UNITED STATES: a) Lot: Z054636AA, Expiry: December 2014; Lot: A014636AA, Expiry: April 2015; Lot: A024636AB, Expiry: July 2015. b) Lot: A014645AA, Expiry: November 2015. c) Lot: A014643AA, Expiry April 2015.

More recalls by Hospira Inc.

View all recalls by this company →

Other recent Class I Drug recalls